Table 3.

Average Annual Change in Facility BZD Prescribing and Facility Strategies to Reduce Prescribing

	Facilities						Facilities
	Low Performing						High Performing
	A	B	C	D	E	F	Q	R	S	T	U	V	W	X	Y	Z
Facility-level annual change (mg/d)	–0.19	–0.21	–0.23	–0.23	–0.24	–0.26	–0.38	–0.39	–0.39	–0.40	–0.40	–0.41	–0.42	–0.46	–0.58	–0.59
Facility size^a	med	small	med	large	small	large	large	large^b	med^b	small^b	small	med^b	large	small	large^b	med
Census region	south	NE	west	NE	south	MW	south	west	west	MW	MW	south	south	west	south	west
Strategies
Passive
Identify hot spots	X		X		X		X	X		X	X	X	X		X	X
Patient- and provider-facing education	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X	X
Provide services and tools			X	X			X	X	X	X		X	X	X	X	X
Active
Provide guidance			X	X	X		X	X		X		X	X	X	X	X
Barriers to prescribing			X		X		X	X	X	X			X		X	X
Performance measures					X		X	X				X			X
Personal authority								X				X		X	X

BZD = benzodiazepine; MW = Midwest; NE = Northeast.
↵a Facilities were placed into size tertiles based on the number of unique individuals aged ≥55 years with health care encounters during the first quarter of phase 2 (small facilities served 7,175-21,228 patients; medium, 21,734-31,296; large, 31,545-84,981).
↵b Nonpriority sites.